explore -WSS

explore

author：Wikipedia 2025-10-01 05:38:42 - browse：257

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： 'Brian's Song' at 50 still offers lessons about cancer for today

knowledge

WSS

Rare Northern Lights show in US this week: Where and how to see it

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Pennsylvania man bitten on the head by bear during attack in his garage

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Why Titanic fascinates society, still drawing tours to the wreckage

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

hotspot

explore

focus

New air purifier tech could be key to improving indoor air quality

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

At least 13 dead in Texas as scorching temps continue

Another man arrested in connection with shooting at Kansas nightclub

Hepatitis C has a cure — but many Americans still lack access to it

US intelligence assessment says Iran not currently developing nuclear weapons

Alkermes shareholders re

It was time to plan for my old age. If only I could stop crying

Trump demands the U.S. pay no more for drugs than other countries … again

Sage considers ways to reduce costs following FDA rejection

knowledge

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Feed a cold, starve a fever? Here’s what science says

How redistricting in 6 states could affect who controls Congress

How corporate America is slashing DEI workers amid backlash to diversity programs

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

entertainment

Wikipedia

knowledge

hotspot